Drug lookup
Drug reference

Cycloserine

Antibacterial · Antituberculosis

AntibacterialAntituberculosisATC null
CDSCO approvedSchedule H
EXCRETION
not curated
INTERACTIONS
5 major
SEVERE in our sources
PREGNANCY
Manufacturer advises use only if potential benefit outweighs risk—crosses the placenta.
FDA category + note
Top interactionssee all 8
  • BupropionSevereDatabaseDDInter
  • EthanolSevereDatabaseDDInter
  • IohexolSevereDatabaseDDInter
  • IopamidolSevereDatabaseDDInter

Mechanism

Cycloserine acts as a structural analog of D-alanine, interfering with bacterial cell wall synthesis. It inhibits two critical enzymes: alanine racemase, which converts L-alanine to D-alanine, and D-alanyl-D-alanine ligase. This dual inhibition prevents the incorporation of D-alanine into the peptidoglycan pentapeptide, thereby disrupting cell wall integrity and leading to bacterial demise, particularly in Mycobacterium tuberculosis.

Indications

Tuberculosis resistant to first-line drugs, in combination with other drugsmultidrug-resistant tuberculosisResistant TB (especially MDR cases)MAC infectionGram-positive bacteria infectionsE. coli infectionsChlamydia infections

Dosing

Adult
Initially 250 mg every 12 hours for 2 weeks, then increased if necessary up to 500 mg every 12 hours by mouth, dose to be increased according to blood concentration and response
Renal adjustment
Increase interval between doses if creatinine clearance less than 50 mL/minute. Monitor blood-cycloserine concentration if creatinine clearance less than 50 mL/minute; blood concentration should not exceed 30 mg/litre.
Max dose
1000 mg/day

Pharmacokinetics

Half-life
9 h
Bioavailability
Almost completely absorbed orally
Metabolism
About 1/3 of a dose is metabolized
Excretion
Urine (50% unchanged in first 12 h, 70% active form over 24 h)

Contraindications

  • Alcohol dependence
  • depression
  • epilepsy
  • psychotic states
  • severe anxiety
  • depression (use with caution)
  • Patients with a history of mental illness or seizures

Side effects

Common
Behaviour abnormalconfusiondrowsinessdysarthriaheadachehyperirritabilitymemory lossneurological effectsparaesthesiaparesisrashreflexes increasedtremorvertigosomnolencesevere psychosisseizuressuicidal ideationsCNS toxicity - headacheSleepinessSlurring of speechAltered behaviourDepressionFall in BP
Serious
  • coma
  • congestive heart failure
  • megaloblastic anaemia
  • psychosis
  • seizures
  • suicidal ideation
  • CNS toxicity
  • allergic dermatitis

Pregnancy & lactation

Pregnancy

Manufacturer advises use only if potential benefit outweighs risk—crosses the placenta.

Lactation

Present in milk—amount too small to be harmful.

Drug interactions

Bupropion
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Ethanol
Severe
Database

Clinical effect not specified

Source: DDInter

Iohexol
Severe
Database

Clinical effect not specified

Source: DDInter

Iopamidol
Severe
Database

Clinical effect not specified

Source: DDInter

Tramadol
Severe
Database

Clinical effect not specified

Source: DDInter

Pyridoxine
Moderate
Textbook

Can lead to pyridoxine deficiency and associated neurological disturbances.

Administer pyridoxine (10–50 mg/day) to prevent and treat cycloserine-induced neurological disturbances.

Source: KDT 7e · p916

Ethionamide
Moderate
Database

Additive CNS toxicity

Monitor mood/seizures

Source: Kimi deep-research + Cla

Ethambutol
Moderate
Database

Additive CNS toxicity (seizures, psychosis, peripheral neuropathy).

Monitor for neuropsychiatric symptoms; use pyridoxine supplementation.

Source: Kimi deep-research + Cla

4 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Other Antibacterial drugs

Ask House about Cycloserine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, Harrison 22e, Katzung·Verified: 2026-05-10 · House clinical team